Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines

Malaysia has granted conditional approval for emergency use to the single dose COVID-19 vaccines manufactured by China's CanSino Biologics and U.S. drugmaker Johnson & Johnson, the government said on Tuesday. The Southeast Asian country has been ramping up its vaccination programme, amid a fresh round of lockdowns imposed this month to curb a surge in coronavirus infections. Malaysia would obtain Johnson & Johnson's vaccines via the global COVAX facility backed by the World Health Organization, the health ministry said in a statement. It did not say how many doses it would procure via COVAX.